2024-05-15 |
2024-05-14 |
B
Purchase
|
Chevallard Daniel R.
Chief Financial Officer
Officer
|
3,188
+inf%
15.68
USD 49,988
|
3,188
+inf%
|
15.68
|
USD 49,988
|
|
2024-05-15 |
2024-05-14 |
B
Purchase
|
Chevallard Daniel R.
Chief Financial Officer
Officer
|
3,188
+inf%
15.68
USD 49,988
|
3,188
+inf%
|
15.68
|
USD 49,988
|
|
2024-05-14 |
2024-05-13 |
B
Purchase
|
MCCOLLUM JAMES W
Non-Executive Director
|
31,332
+6.3%
15.99
USD 501,093
|
31,332
+6.3%
|
15.99
|
USD 501,093
|
|
2024-03-25 |
2024-03-21 |
B
Purchase
|
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director
Large shareholder
|
64,971
+10.3%
15.03
USD 976,514
|
64,971
+10.3%
|
15.03
|
USD 976,514
|
|
2024-03-25 |
2024-03-21 |
B
Purchase
|
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director
Large shareholder
|
933,038
+39.1%
15.03
USD 14,023,561
|
933,038
+39.1%
|
15.03
|
USD 14,023,561
|
|
2022-04-13 |
2022-04-12 |
B
Purchase
|
Samsara BioCapital, L.P.
Large shareholder
|
350,000
+4.3%
4.08
USD 1,428,000
|
350,000
+4.3%
|
4.08
|
USD 1,428,000
|
|
2022-04-13 |
2022-04-11 |
PP
Planned purchase
|
Gutry Phil
CHIEF BUSINESS OFFICER
Officer
|
5,000
+1.7%
4.01
USD 20,050
|
5,000
+1.7%
|
4.01
|
USD 20,050
|
|
2022-04-13 |
2022-04-11 |
B
Purchase
|
Samsara BioCapital, L.P.
Large shareholder
|
74,464
+0.9%
4.07
USD 303,068
|
74,464
+0.9%
|
4.07
|
USD 303,068
|
|
2022-01-25 |
2022-01-24 |
B
Purchase
|
Samsara BioCapital, L.P.
Large shareholder
|
23,000
+0.3%
8.70
USD 200,100
|
23,000
+0.3%
|
8.70
|
USD 200,100
|
|
2022-01-25 |
2022-01-21 |
B
Purchase
|
Samsara BioCapital, L.P.
Large shareholder
|
100,000
+1.3%
8.99
USD 899,000
|
100,000
+1.3%
|
8.99
|
USD 899,000
|
|
2022-01-21 |
2022-01-20 |
B
Purchase
|
Samsara BioCapital, L.P.
Large shareholder
|
43,105
+0.5%
8.92
USD 384,497
|
43,105
+0.5%
|
8.92
|
USD 384,497
|
|
2022-01-21 |
2022-01-19 |
B
Purchase
|
Samsara BioCapital, L.P.
Large shareholder
|
54,565
+0.7%
9.24
USD 504,181
|
54,565
+0.7%
|
9.24
|
USD 504,181
|
|
2021-12-20 |
2021-12-15 |
B
Purchase
|
Samsara BioCapital, L.P.
Large shareholder
|
22,329
+0.3%
10.19
USD 227,533
|
22,329
+0.3%
|
10.19
|
USD 227,533
|
|
2021-11-24 |
2021-11-22 |
B
Purchase
|
Samsara BioCapital, L.P.
Large shareholder
|
201,685
+2.7%
10.15
USD 2,047,103
|
201,685
+2.7%
|
10.15
|
USD 2,047,103
|
|
2021-10-15 |
2021-10-15 |
B
Purchase
|
Samsara BioCapital, L.P.
Large shareholder
|
2,300
+0.0%
12.49
USD 28,727
|
2,300
+0.0%
|
12.49
|
USD 28,727
|
|
2021-10-15 |
2021-10-14 |
B
Purchase
|
Samsara BioCapital, L.P.
Large shareholder
|
3,100
+0.0%
12.50
USD 38,750
|
3,100
+0.0%
|
12.50
|
USD 38,750
|
|
2021-10-15 |
2021-10-13 |
B
Purchase
|
Samsara BioCapital, L.P.
Large shareholder
|
45,400
+0.6%
13.22
USD 600,188
|
45,400
+0.6%
|
13.22
|
USD 600,188
|
|
2021-10-08 |
2021-10-08 |
B
Purchase
|
Samsara BioCapital, L.P.
Large shareholder
|
75,000
+1.0%
13.12
USD 984,000
|
75,000
+1.0%
|
13.12
|
USD 984,000
|
|
2021-10-08 |
2021-10-07 |
B
Purchase
|
Samsara BioCapital, L.P.
Large shareholder
|
9,021
+0.1%
14.94
USD 134,774
|
9,021
+0.1%
|
14.94
|
USD 134,774
|
|
2021-10-08 |
2021-10-06 |
B
Purchase
|
Samsara BioCapital, L.P.
Large shareholder
|
61,475
+0.8%
13.83
USD 850,199
|
61,475
+0.8%
|
13.83
|
USD 850,199
|
|